X-22033015-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2
The NM_000444.6(PHEX):āc.10G>Cā(p.Glu4Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000234 in 1,203,671 control chromosomes in the GnomAD database, including 1 homozygotes. There are 105 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.00036 ( 0 hom., 14 hem., cov: 22)
Exomes š: 0.00022 ( 1 hom. 91 hem. )
Consequence
PHEX
NM_000444.6 missense
NM_000444.6 missense
Scores
2
6
9
Clinical Significance
Conservation
PhyloP100: 6.17
Genes affected
PHEX (HGNC:8918): (phosphate regulating endopeptidase X-linked) The protein encoded by this gene is a transmembrane endopeptidase that belongs to the type II integral membrane zinc-dependent endopeptidase family. The protein is thought to be involved in bone and dentin mineralization and renal phosphate reabsorption. Mutations in this gene cause X-linked hypophosphatemic rickets. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0057458878).
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000362 (40/110555) while in subpopulation EAS AF= 0.00538 (19/3529). AF 95% confidence interval is 0.00352. There are 0 homozygotes in gnomad4. There are 14 alleles in male gnomad4 subpopulation. Median coverage is 22. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 14 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHEX | NM_000444.6 | c.10G>C | p.Glu4Gln | missense_variant | 1/22 | ENST00000379374.5 | NP_000435.3 | |
PHEX | NM_001282754.2 | c.10G>C | p.Glu4Gln | missense_variant | 1/21 | NP_001269683.1 | ||
PHEX | XM_047442159.1 | c.10G>C | p.Glu4Gln | missense_variant | 1/13 | XP_047298115.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHEX | ENST00000379374.5 | c.10G>C | p.Glu4Gln | missense_variant | 1/22 | 1 | NM_000444.6 | ENSP00000368682.4 | ||
PHEX | ENST00000684143.1 | c.10G>C | p.Glu4Gln | missense_variant | 1/11 | ENSP00000508264.1 | ||||
PHEX | ENST00000475778.2 | n.436G>C | non_coding_transcript_exon_variant | 1/9 | 5 | |||||
PHEX | ENST00000683214.1 | n.436G>C | non_coding_transcript_exon_variant | 1/2 |
Frequencies
GnomAD3 genomes AF: 0.000362 AC: 40AN: 110503Hom.: 0 Cov.: 22 AF XY: 0.000428 AC XY: 14AN XY: 32715
GnomAD3 genomes
AF:
AC:
40
AN:
110503
Hom.:
Cov.:
22
AF XY:
AC XY:
14
AN XY:
32715
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000731 AC: 134AN: 183399Hom.: 1 AF XY: 0.000634 AC XY: 43AN XY: 67855
GnomAD3 exomes
AF:
AC:
134
AN:
183399
Hom.:
AF XY:
AC XY:
43
AN XY:
67855
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000221 AC: 242AN: 1093116Hom.: 1 Cov.: 29 AF XY: 0.000254 AC XY: 91AN XY: 358700
GnomAD4 exome
AF:
AC:
242
AN:
1093116
Hom.:
Cov.:
29
AF XY:
AC XY:
91
AN XY:
358700
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000362 AC: 40AN: 110555Hom.: 0 Cov.: 22 AF XY: 0.000427 AC XY: 14AN XY: 32777
GnomAD4 genome
AF:
AC:
40
AN:
110555
Hom.:
Cov.:
22
AF XY:
AC XY:
14
AN XY:
32777
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
89
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Familial X-linked hypophosphatemic vitamin D refractory rickets Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
Uncertain significance, criteria provided, single submitter | reference population | Soonchunhyang University Bucheon Hospital, Soonchunhyang University Medical Center | Mar 18, 2016 | - - |
not specified Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 26, 2016 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Feb 21, 2017 | - - |
PHEX-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 14, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Pathogenic
D
MetaRNN
Benign
T
MetaSVM
Uncertain
T
MutationAssessor
Benign
L
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Benign
T
Sift4G
Benign
T
Polyphen
D
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at